Reaction

Catheter Site Swelling reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 907 reports · 26 co-occurring drugs

As of the last recalculation, Catheter Site Swelling appears in 907 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 299.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Epoprostenol144299.9303.2
Macitentan14557.057.1
Sildenafil10144.945.0
Treprostinil19344.644.6
Sildenafil Powder,6444.344.4
Riociguat5138.038.0
Sildenafil Citrate15834.334.3
Tadalafil12733.733.7
Bosentan6431.331.3
0Xygen4823.623.6
Oxygen4823.623.6
Ambrisentan9920.320.3
Sodium Chloride Tablet5718.918.9
Sodium Chloride Tablets5718.918.9
Adrenalinum3218.318.3
Sodium Chloride5817.917.9
Ketoprofen1017.717.7
Teduglutide915.515.5
Cetirizine Hcl615.115.1
Selexipag1513.513.5
Umeclidinium512.912.9
Agalsidase Beta512.512.5
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose411.211.3
Ravulizumab58.58.5
Alteplase57.77.7
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride86.06.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.